End Tuberculosis Now Act of 2026

The End Tuberculosis Now Act of 2026 amends the Foreign Assistance Act to designate ending the global tuberculosis emergency as a major objective of U.S. foreign policy and authorizes the President to provide funding for prevention, diagnosis, and treatment programs worldwide. The bill sets specific targets to be achieved by 2030, including an 80 percent reduction in new infections and a 90 percent reduction in deaths compared to 2015 levels, while also requiring that 30 million individuals receive preventive treatment. Key provisions mandate the use of innovative diagnostic tools, support for drug-resistant TB care, and coordination with private sector partners to develop vaccines and lower treatment costs. The legislation requires annual reports to Congress detailing program progress and expenditures, and it includes a sunset clause that terminates these specific authorities on January 1, 2033.